Opinion: Neko Health Bets $700 Million on US Expansion, but Scaling Struggles and Custom Tech Raise Questions
AI-generated image · Bay Street Wire
Backed by a roster of tech billionaires and celebrities, Daniel Ek's body-scanning startup is bringing its high-end screening clinics to New York.
Neko Health is attempting to shift preventative medicine from reactive care to proactive screening, but the company's reliance on custom hardware suggests it may be catering more to the biohacking elite than the general public.
As The Verge reported, the startup—cofounded by Spotify founder Daniel Ek and CEO Hjalmar Nilsonne—has raised $700 million to fuel its entry into the United States. The company plans to launch its first US clinic in New York this year, with Nilsonne stating the funding will support the mission to make prevention possible at scale. While a waitlist for the New York site is currently open, Neko has not disclosed a specific timeline or additional city locations for its US rollout.
**The Hardware Play**
Neko's model centers on private clinics utilizing AI and custom-built medical equipment to perform full-body scans and blood tests. The goal, as stated by the company, is to identify early markers for diabetes, heart disease, and skin cancer to extend human longevity. This approach targets a growing market of longevity enthusiasts and those seeking alternatives to traditional healthcare systems that typically intervene only after symptoms manifest.
**A Star-Studded Cap Table**
The company's latest funding round reflects a heavy investment from the ultra-wealthy. The Verge reports that new investors include Meta chief Mark Zuckerberg and Priscilla Chan, musician will.i.am, tennis player Maria Sharapova, and former footballer Thierry Henry. Existing backers include actor Zoë Saldaña and Reddit cofounder Alexis Ohanian. While Neko has not officially released a valuation, The Verge notes that unnamed sources cited by the Financial Times place the company's valuation at approximately $7 billion.
**Scaling Challenges and Costs**
Neko currently operates eight clinics across Sweden and the UK, with two in Stockholm and four in London. The cost of these scans varies by region: £299 in the UK (roughly $400) and 2,750 Swedish kronor in Sweden (roughly $285). Neko has not yet announced pricing for its US operations.
Despite the high demand—with the company claiming 100,000 people have been scanned and over 350,000 have registered or joined waitlists—The Verge reports that Neko has struggled to keep pace with this demand as it attempts to scale its operations.
*Opinion: While the $700 million war chest is impressive, Neko is essentially betting that proprietary hardware can replace the foundational role of primary care. As The Verge reports, the company has struggled to keep pace with demand as it scales, and it has not disclosed US pricing or a detailed rollout timeline. Unless Neko can demonstrate that its scans complement traditional healthcare rather than simply serve a wealthy, tech-forward demographic, it risks being viewed as an expensive novelty for the 1% rather than a scalable medical breakthrough.*